← Human Trials & Peer-Reviewed Studies

The Role of Vitamin D in the Transcriptional Program of Human Pregnancy.

Plain-language guide to PMID 27711190 (2016): randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 30 women.

Key Facts

PMID
27711190
Journal
PloS one
Year
2016
Study type
Randomized Controlled Trial
Authors
Al-Garawi A et al. (10 authors)
DOI
10.1371/journal.pone.0163832
Registered trial
NCT00920621

What This Study Did, in Plain Language

What Was Tested

The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a randomized controlled trial.

In this study, the researchers used a network-based approach to examine changes in gene expression profiles during the course of normal pregnancy and evaluated their association with maternal Vitamin D levels.

Why It Was Studied

Patterns of gene expression of human pregnancy are poorly understood.

Who Took Part

The study group was 30 women.

The age groups tagged for this paper are young adults and adults, women only.

In a trial of vitamin D supplementation in pregnant women, peripheral blood transcriptomes were measured longitudinally on 30 women and used to characterize gene co-expression networks.

The trial enrolled 881 women at 10-18 weeks of gestation.

How the Study Was Run

In design terms this was a randomized study.

Because people in this Vitamin D, K2, Magnesium and Zinc study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

Longitudinal gene expression measures were obtained on thirty pregnant women, using RNA isolated from peripheral blood samples obtained in the first and third trimesters.

Gene-set enrichment was performed to identify major biological pathways.

What Was Measured

Topics PubMed links to this paper include Fetal Development, Gene Regulatory Networks, Transcription, Genetic, Transcriptome and Vitamin D.

What This Means in Plain Language

The paper is a randomized study of Vitamin D, K2, Magnesium and Zinc in 30 women.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

Its findings take up roughly 5 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2016 (PloS one), a journal based in United States.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.

Our Notes on the Compound

Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.